News

January 24, 2011 – Patient enrollment was completed in the EVOLVE clinical trial, which is designed to assess the safety and performance of the Boston Scientific's fourth-generation Synergy coronary stent, which uses a bioabsorbable drug-eluting polymer.

Home January 24, 2011
Home
News

January 24, 2011 – The first U.S. clinical implant of a device designed to restore more natural breathing patterns in patients with central sleep apnea was made last week at The Ohio State University Medical Center, Columbus.

Home January 24, 2011
Home
The microbubbles that make up the ultrasound contrast agent Optison from GE Healthcare.
Feature

http://www.echocontrast.nl/Contrast-enhanced ultrasound (CEUS) can "dramatically improve" physicians' ability to detect heart disease and stratify future risk, said Thomas Porter, M.D., at the 16th European Symposium on Ultrasound Contrast Imaging in Rotterdam.

Home January 24, 2011
Home
News

January 21, 2011 – The U.S. Food and Drug Administration (FDA) this week unveiled a plan containing 25 actions it intends to implement during 2011 to improve its 510(k) review of medical technology, the most common path to market for medical devices.

Home January 21, 2011
Home
News

January 21, 2011 – Intravascular ultrasound (IVUS) enabled physicians to more accurately assess the risk of individual blockages than the use of the current standard of angiographic imaging alone, according to a new study.

Home January 21, 2011
Home
News

January 20, 2011 – European CE mark approval was granted to expand the indication of Abbott’s Xience Prime everolimus-eluting coronary stent for the treatment of critical limb ischemia (CLI) or severe claudication (pain) of the lower leg. CLI is the most advanced form of peripheral artery disease (PAD) that can ultimately lead to limb amputation.

Home January 21, 2011
Home
Feature

The Society for Cardiovascular Angiography and Interventions (SCAI) this week published guiding principles and best practices for the development of radiation safety programs in cardiac catheterization laboratories.

Home January 20, 2011
Home
News

January 20, 2011 – Results from a large, worldwide, clinical trial show evidence that a first-of-its-kind pacemaker system is safe and effective to use during magnetic resonance imaging (MRI). During the trial, no MRI-related complications were reported in patients with the pacemaker system before, during, or after an MRI examination.

Home January 20, 2011
Home
News

Continuing to build a portfolio of transcatheter structural heart technology, Boston Scientific today signed a definitive merger agreement to acquire Atritech Inc. Atritech developed the Watchman device, which is designed to close the left atrial appendage (LAA) in patients with atrial fibrillation who are at risk for ischemic stroke.

Home January 19, 2011
Home
News

January 19, 2011 – The patient support group Mended Hearts, in partnership with Daiichi Sankyo Inc. and Eli Lilly and Company, this week launched the Stent Hub – an online patient and caregiver resource for acute coronary syndrome (ACS) patients who were treated with percutaneous coronary intervention (PCI).

Home January 19, 2011
Home
Technology

January 19, 2011 – GE Healthcare and Veran announced a strategic supplier agreement this week in which GE became the exclusive distributor and reseller of Veran’s ig4 fusion imaging angiography navigation system in the United States.

Home January 19, 2011
Home
Feature

January 19, 2011 – The U.S. Food and Drug Administration (FDA) granted conditional approval to modify the CoreValve U.S. pivotal clinical trial to eliminate the medical management arm of the study.

Home January 19, 2011
Home
News

January 19, 2011 – Stents can open up blocked brain arteries after other stroke treatments have failed, according to research presented this week at the 23rd annual International Symposium on Endovascular Therapy (ISET).

Home January 18, 2011
Home
News

January 19, 2011 – Siemens Healthcare is partnering with Endosense for the integration of the contact-force data provided by Endosense’s TactiCath force-sensing ablation catheter with Siemens’ electrophysiology (EP) solutions.

Home January 18, 2011
Home
News

January 18, 2011 – The first endovascular device approved for the treatment of pulmonary embolism (PE) was granted CE-mark approval this week in Europe. The Ekos EkoSonic Endovascular System was originally designed and approved to dissolve blood clots in the arms and legs.

Home January 18, 2011
Home
Subscribe Now